Go Pro
→ Elon's next move will be bigger than the IPO – and it could happen any day now (From Brownstone Research) (Ad)tc pixel Free LYEL Stock Alerts

Lyell Immunopharma (LYEL) Short Interest Ratio & Short Volume

Lyell Immunopharma logo
$13.32 0.00 (0.00%)
Closing price 07/17/2026 04:00 PM Eastern
Extended Trading
$13.43 +0.11 (+0.82%)
As of 07:20 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Lyell Immunopharma Short Interest Overview

As of June 30, 2026, Lyell Immunopharma (LYEL) had a short interest of 1.22 million shares sold short, representing 5.59% of the public float. This marks a -7.09% decrease in short interest since the prior report. The short interest ratio (days to cover) is 3.4, meaning it would take 3.4 days of the average trading volume of 250,725 shares to cover all short positions.

Current Short Interest
1,223,220 shares
Previous Short Interest
1,316,562 shares
Change Vs. Previous Month
-7.09%
Dollar Volume Sold Short
$17.19 million
Short Interest Ratio
3.4 Days to Cover
Last Record Date
June 30, 2026
Outstanding Shares
24,500,000 shares
Short Percent of Float
5.59%
Today's Trading Volume
168,668 shares
Average Trading Volume
250,725 shares
Today's Volume Vs. Average
67%
Short Selling Lyell Immunopharma?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Lyell Immunopharma and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

LYEL Short Interest Over Time

LYEL Days to Cover Over Time

LYEL Percentage of Float Shorted Over Time

Lyell Immunopharma Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/20261,223,220 shares $17.19 million -7.1%5.6%3.44 $14.05
6/15/20261,316,562 shares $17.84 million -2.7%6.0%9.62 $13.55
5/29/20261,353,275 shares $23.45 million +1.0%6.2%16.21 $17.33
5/15/20261,340,406 shares $24.02 million -0.3%6.1%23.25 $17.92
4/30/20261,344,189 shares $26.52 million +8.9%6.1%18.78 $19.73
4/15/20261,234,370 shares $29.43 million +8.4%5.6%12.04 $23.84
3/31/20261,138,296 shares $22.83 million +21.1%6.3%12.78 $20.06
3/13/2026940,269 shares $19.98 million +15.3%5.2%8.59 $21.25
2/27/2026815,248 shares $19.57 million +37.7%4.9%7.63 $24.00
2/13/2026592,027 shares $15.30 million +13.6%2.7%6.28 $25.84
1/30/2026521,115 shares $12.51 million +28.0%3.2%6.09 $24.00
1/15/2026407,278 shares $9.34 million +69.2%2.5%3.96 $22.93
12/31/2025240,730 shares $7.41 million +46.4%1.5%1.58 $30.78
12/15/2025164,482 shares $5.33 million +1.7%1.0%2.44 $32.40
11/28/2025161,792 shares $5.24 million -0.8%1.0%3.35 $32.40
11/14/2025163,125 shares $2.76 million -1.9%1.0%5.91 $16.93
10/31/2025166,193 shares $2.77 million -9.6%1.1%6.54 $16.66
10/15/2025183,900 shares $3.20 million -21.1%2.1%3.5 $17.38
9/30/2025233,100 shares $3.79 million +43.4%2.7%4.4 $16.24
9/15/2025162,600 shares $2.13 million +11.6%1.9%2.1 $13.13
8/31/2025145,700 shares $1.61 million +9.6%1.7%1.7 $11.08
8/15/2025133,000 shares $1.41 million -29.3%2.4%1 $10.58
7/31/2025188,200 shares $2.22 million -22.8%3.3%1.3 $11.81
7/15/2025243,800 shares $2.22 million -6.5%3.6%1.9 $9.10
6/30/2025260,600 shares $2.30 million -26.7%4.0%2 $8.84
6/15/2025355,300 shares $3.46 million -33.2%5.6%3.4 $9.74
5/31/2025531,500 shares $0.00 -94.5%8.8%5.7 $0.00
5/15/20259,710,000 shares $3.90 million +71.6%8.1%12.6 $0.40
4/30/20255,660,000 shares $2.69 million +0.4%4.5%5.9 $0.48
4/15/20255,640,000 shares $2.59 million -1.2%4.5%5.8 $0.46
3/31/20255,710,000 shares $3.07 million -4.5%4.6%5.7 $0.54
3/15/20255,980,000 shares $3.50 million -26.1%4.8%5.5 $0.59
2/28/20258,090,000 shares $5.75 million -16.2%6.5%7 $0.71
2/15/20259,650,000 shares $5.89 million -16.3%7.7%7.6 $0.61
1/31/202511,530,000 shares $6.81 million -7.0%7.6%9.4 $0.59
1/15/202512,400,000 shares $7.41 million +0.7%8.2%8.2 $0.60
12/31/202412,310,000 shares $7.88 million +12.0%8.5%8.5 $0.64
12/15/202410,990,000 shares $7.41 million +16.3%7.6%7.7 $0.67
11/30/20249,450,000 shares $8.93 million -1.6%7.2%7.3 $0.95
11/15/20249,600,000 shares $10.56 million -13.8%7.7%7.7 $1.10
Confirm Your Name Before the Letter Goes Out (Ad)

Americans who believe in real retirement protection are adding their names to a statement going out to Washington and Wall Street. It's a message that people are fed up with inflation and the erosion of their savings. President Trump took a stand on protecting American wealth. Now you can add your voice while also learning how to move part of your IRA or 401(k) into physical gold and silver, tax and penalty free.tc pixel

Add your name and claim your free Gold IRA Guide today.
10/31/202411,140,000 shares $10.70 million +3.5%8.9%10.3 $0.96
10/15/202410,760,000 shares $12.59 million +0.9%9.4%17.1 $1.17
9/30/202410,660,000 shares $14.71 million -19.4%9.4%16 $1.38
9/15/202413,220,000 shares $16.26 million -3.9%11.6%13.8 $1.23
8/31/202413,760,000 shares $19.95 million -8.5%12.1%14.6 $1.45
8/15/202415,030,000 shares $18.86 million -7.9%13.3%15.9 $1.26
7/31/202416,320,000 shares $26.28 million +1.2%13.6%16.9 $1.61
7/15/202416,130,000 shares $27.74 million -10.0%13.6%16.6 $1.72
6/30/202417,920,000 shares $25.98 million -25.8%15.1%16.9 $1.45
6/15/202424,150,000 shares $56.99 million +19.6%20.4%30.6 $2.36
5/31/202420,200,000 shares $55.95 million +0.5%17.1%25.2 $2.77
5/15/202420,100,000 shares $52.46 million +0.7%17.0%23.3 $2.61
4/30/202419,970,000 shares $43.33 million +9.5%16.9%22.3 $2.17
4/15/202418,230,000 shares $43.75 million +0.7%15.5%19.8 $2.40
3/31/202418,100,000 shares $40.36 million +74.4%15.5%18.8 $2.23
3/15/202410,380,000 shares $22.42 million -5.2%8.9%10.3 $2.16
2/29/202410,950,000 shares $31.97 million -39.6%9.4%8.9 $2.92
2/15/202418,130,000 shares $34.45 million +67.3%15.7%14.5 $1.90
1/31/202410,840,000 shares $19.84 million -30.6%9.4%8.2 $1.83
1/15/202415,620,000 shares $34.68 million +4.4%12.7%11.8 $2.22
12/31/202314,960,000 shares $29.02 million -13.2%12.1%12.2 $1.94
12/15/202317,240,000 shares $33.10 million -0.6%14.0%15.3 $1.92
11/30/202317,340,000 shares $30.00 million -2.3%14.1%18.8 $1.73
11/15/202317,740,000 shares $36.37 million -7.6%14.4%20.3 $2.05
10/31/202319,200,000 shares $31.78 million -7.3%15.8%25.1 $1.66
10/15/202320,720,000 shares $33.98 million -2.3%17.1%29.2 $1.64
9/30/202321,210,000 shares $31.18 million +1.3%17.5%30 $1.47
9/15/202320,930,000 shares $35.37 million -5.2%17.2%28.3 $1.69
8/31/202322,070,000 shares $52.75 million -3.7%18.3%24.3 $2.39
8/15/202322,910,000 shares $52.46 million -2.5%19.0%23 $2.29
7/31/202323,500,000 shares $67.92 million +1.5%19.6%22 $2.89
7/15/202323,160,000 shares $67.86 million -1.2%19.3%20.9 $2.93
6/30/202323,450,000 shares $74.57 million +3.9%19.6%20.8 $3.18
6/15/202322,580,000 shares $87.16 million +4.9%18.9%18.7 $3.86
5/31/202321,530,000 shares $68.68 million +2.8%18.0%20.1 $3.19
5/15/202320,950,000 shares $63.06 million +3.2%17.5%19.8 $3.01
4/30/202320,300,000 shares $41.21 million -0.7%17.0%20.1 $2.03
4/15/202320,450,000 shares $48.26 million -1.8%17.1%20.9 $2.36
3/31/202320,830,000 shares $49.16 million +1.3%17.4%20.2 $2.36
3/15/202320,560,000 shares $45.03 million +14.2%17.2%19.6 $2.19
2/28/202318,010,000 shares $38.72 million +5.4%15.1%16.2 $2.15
2/15/202317,080,000 shares $42.70 million -2.1%14.3%15.7 $2.50
1/31/202317,440,000 shares $57.03 million -2.9%14.6%15.2 $3.27
1/15/202317,960,000 shares $58.01 million -9.4%15.0%15.5 $3.23
12/30/202219,820,000 shares $68.78 million +15.8%20.3%18 $3.47
12/15/202217,110,000 shares $56.12 million -2.0%17.5%16.1 $3.28
11/30/202217,450,000 shares $73.46 million -5.7%22.0%15.3 $4.21
11/15/202218,510,000 shares $85.15 million -2.5%23.4%16.5 $4.60
10/31/202218,990,000 shares $111.66 million -1.1%23.4%18.6 $5.88
10/15/202219,200,000 shares $125.57 million +5.1%23.6%18.6 $6.54
Elon's next move will be bigger than the IPO – and it could happen any day now (Ad)

Hedge fund legend Larry Benedict - who delivered a 279% return on cash in 2025 and went on a 20-year winning streak - says the SpaceX IPO wasn't the main event. It was the trigger. He's identified what he calls the 'Final Phase of Elon's Master Plan,' and one specific ticker he believes could see billions forced into it within days. It's not SpaceX, Tesla, or any company you'd associate with Elon Musk. Larry is revealing the ticker free today.tc pixel

Watch Larry Benedict's presentation and get the one ticker now
9/30/202218,270,000 shares $133.92 million +19.3%22.5%18.6 $7.33
9/15/202215,320,000 shares $121.95 million +7.0%19.1%14.7 $7.96
8/31/202214,320,000 shares $95.94 million -7.2%18.1%15.6 $6.70
8/15/202215,430,000 shares $116.03 million -4.6%19.5%17.1 $7.52
7/31/202216,180,000 shares $90.12 million -4.9%25.4%17.1 $5.57
7/15/202217,010,000 shares $100.36 million -2.4%26.7%19.1 $5.90
6/30/202217,430,000 shares $113.64 million +6.9%27.4%19.3 $6.52
6/15/202216,310,000 shares $77.15 million +1.8%25.6%17.9 $4.73
5/31/202216,030,000 shares $66.36 million +5.6%25.4%13 $4.14
5/15/202215,180,000 shares $60.57 million -2.9%24.1%11.9 $3.99
4/30/202215,640,000 shares $80.23 million -6.0%26.4%12.3 $5.13
4/15/202216,630,000 shares $89.64 million +5.3%28.1%13 $5.39
3/31/202215,800,000 shares $79.79 million +29.7%26.7%12.3 $5.05
3/15/202212,180,000 shares $73.20 million +21.7%21.0%9 $6.01
2/28/202210,010,000 shares $72.47 million +6.0%17.3%11.3 $7.24
2/15/20229,440,000 shares $64.38 million +9.6%16.4%12.4 $6.82
1/31/20228,610,000 shares $48.90 million +2.7%14.9%12.9 $5.68
1/15/20228,380,000 shares $50.62 million +10.1%14.5%14.8 $6.04
12/31/20217,610,000 shares $58.90 million +22.4%13.2%15.1 $7.74
12/15/20216,220,000 shares $55.98 million +17.4%10.8%13 $9.00
11/30/20215,300,000 shares $50.62 million +7.1%9.9%12.1 $9.55
11/15/20214,950,000 shares $54.70 million No Change9.3%10.7 $11.05
10/29/20214,950,000 shares $69.00 million +3.8%9.2%11.5 $13.94
10/15/20214,770,000 shares $63.35 million +11.7%8.9%11 $13.28
9/30/20214,270,000 shares $63.20 million +10.3%8.0%9.1 $14.80
9/15/20213,870,000 shares $51.01 million +15.2%5.2%8.2 $13.18
8/31/20213,360,000 shares $53.05 million +10.2%4.4%7.1 $15.79
8/13/20213,050,000 shares $45.17 million No Change4.0%6.7 $14.81

LYEL Short Interest - Frequently Asked Questions

Short interest is the volume of Lyell Immunopharma shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 1,223,220 shares of LYEL short. 5.59% of Lyell Immunopharma's shares are currently sold short. Learn More on Lyell Immunopharma's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LYEL shares currently have a short interest ratio of 3.4. Learn More on Lyell Immunopharma's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.59% of Lyell Immunopharma's floating shares are currently sold short.

Lyell Immunopharma saw a decline in short interest during the month of June. As of June 30th, there was short interest totaling 1,223,220 shares, a decline of 7.1% from the previous total of 1,316,562 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

5.59% of Lyell Immunopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Lyell Immunopharma: Ardelyx, Inc. (10.84%), Immatics N.V. (4.17%), Corvus Pharmaceuticals, Inc. (27.87%), Avalyn Pharma Inc. (4.88%), Schrodinger, Inc. (15.83%), Capricor Therapeutics, Inc. (28.03%), Savara Inc. (16.50%), WAVE Life Sciences Ltd. (14.35%), MeiraGTx Holdings PLC (5.50%), Collegium Pharmaceutical, Inc. (17.17%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($82.01 billion), Invesco QQQ ($47.15 billion), iShares Russell 2000 ETF ($24.07 billion), Nebius Group N.V. ($16.85 billion), Western Digital Corporation ($14.29 billion), SPDR S&P Biotech ETF ($11.89 billion), VanEck Semiconductor ETF ($11.29 billion), KLA Corporation ($10.37 billion), iShares 20+ Year Treasury Bond ETF ($8.78 billion), and Lumentum Holdings Inc. ($8.29 billion). View all of the most shorted stocks.

Short selling LYEL is an investing strategy that aims to generate trading profit from Lyell Immunopharma as its price is falling. LYEL shares are trading down $0.57 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Lyell Immunopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LYEL, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LYEL, twice per month. The most recent reporting period available is June, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like LYEL:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:LYEL) was last updated on 7/10/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Not oil. Not solar. Bigger.
The International Energy Agency measured it at 140 times global electricity demand. It runs 24 hours a day, pr...
Behind the Markets | Sponsoredtc pixel
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
Buy this stock tomorrow
Marc Chaikin, founder of Chaikin Analytics, is flagging a little-known company that just secured a partnership...
Chaikin Analytics | Sponsoredtc pixel
Trump’s $250 Bill – See Immediately
Former Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...
Stansberry Research | Sponsoredtc pixel
American’s Biggest Threat Is Here
This feels like one of those ''where were you when Kennedy was shot'' moments. It felt like a moment in time, ...
Goldco Direct, LLC | Sponsoredtc pixel
This same-day trade is getting a lot of attention
Zero-days-to-expiration trades happen every single day - and most traders either ignore them or use them wrong...
Base Camp Trading | Sponsoredtc pixel
The chipmaker 148 times smaller than NVIDIA supplying Musk
According to Yahoo Finance, Elon Musk's latest project could 'upend another industry just as he did with cars ...
Brownstone Research | Sponsoredtc pixel